Answers are grounded in this paper and cite their sources.
Hydrogel-based tissue adhesives hold promise for diverse biomedical applications, yet achieving strong, durable adhesion to wet, dynamic biological surfaces remains challenging. The catechol-containing amino acid 3,4-dihydroxy-l-phenylalanine (DOPA) is a crucial functional motif in mussel-inspired adhesives and has been extensively investigated for incorporation into various biomaterials. However, conventional approaches of DOPA incorporation and subsequent crosslinking have shown limited potential for clinical translation. We developed a bioinspired strategy involving pH-controlled enzymatic conversion of tyrosine residues in porcine gelatin into DOPA. The resulting catechol-functionalized gelatin was blended with native tyrosine-rich gelatin to form a hybrid adhesive hydrogel, termed DOPA-tyrosine gelatin (DTG) bioglue. DTG was designed to achieve (a) rapid visible-light-driven ruthenium-based crosslinking for structural integrity and (b) enhanced interfacial adhesion via DOPA-mediated interactions with tissue surface. Its shear-thinning and fast-curing properties enable its use as a bioink for both extrusion-based and digital-light-processing 3-dimensional bioprinting. We demonstrated the DTG-assisted tissue-tissue integration for large-area construct assembly, addressing current volumetric fabrication limitations in microextrusion bioprinting. Moreover, it demonstrated superior hemostatic performance in rat liver and vascular injury models. Collectively, DTG bioglue is a promising candidate for next-generation adhesive biomaterial for regenerative medicine and surgical applications.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: